BREAKING
Apollo Q4 2025 Earnings Rocket: Historic AUM Breakthrough 44 minutes ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 2 hours ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 5 hours ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 7 hours ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 7 hours ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 8 hours ago Earnings Summary: Loews Corporation reports sharp increase in Q4 FY25 profit 9 hours ago Plains All American weakens as NGL divestiture and cost cuts frame muted 2026 growth 11 hours ago Plains All American Streamlines, Targets Crude Growth Amid NGL Exit 11 hours ago Operational Efficiency Powers MGY to Historic Production and Dividend Lift 12 hours ago Apollo Q4 2025 Earnings Rocket: Historic AUM Breakthrough 44 minutes ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 2 hours ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 5 hours ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 7 hours ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 7 hours ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 8 hours ago Earnings Summary: Loews Corporation reports sharp increase in Q4 FY25 profit 9 hours ago Plains All American weakens as NGL divestiture and cost cuts frame muted 2026 growth 11 hours ago Plains All American Streamlines, Targets Crude Growth Amid NGL Exit 11 hours ago Operational Efficiency Powers MGY to Historic Production and Dividend Lift 12 hours ago
ADVERTISEMENT
Market News

Main takeaways from Accenture’s (ACN) Q4 2025 earnings report

Shares of Accenture (NYSE: ACN) dropped over 1% on Thursday, despite the company delivering better-than-expected earnings results for the fourth quarter of 2025. The top and bottom line numbers saw growth versus the year-ago period and came ahead of expectations. The company has forecast revenue and earnings growth for the upcoming year as well. Results […]

$ACN September 25, 2025 2 min read

Shares of Accenture (NYSE: ACN) dropped over 1% on Thursday, despite the company delivering better-than-expected earnings results for the fourth quarter of 2025. The top and bottom line numbers saw growth versus the year-ago period and came ahead of expectations. The company has forecast revenue and earnings growth for the upcoming year as well.

Results beat estimates

In Q4 2025, Accenture’s total revenues increased 7% year-over-year to $17.60 billion, beating estimates of $17.34 billion. Revenues grew 4.5% in local currency. On a GAAP basis, earnings per share decreased 15% to $2.25 versus the previous year. Adjusted EPS grew 9% YoY to $3.03, surpassing projections of $2.96.  

Bookings and segment revenue growth

In the fourth quarter of 2025, Accenture’s new bookings increased 6% YoY to $21.31 billion. Of this, new bookings in Consulting totaled $8.87 billion while bookings in Managed Services amounted to $12.44 billion. Generative AI new bookings were $1.8 billion.

In Q4, revenues from Consulting grew 6% YoY to $8.77 billion while revenues from Managed Services rose 8% to $8.82 billion. The company saw revenue growth across all its geographies, with EMEA and Asia Pacific delivering double-digit growth while Americas recorded a 5% increase.

Accenture also saw revenues grow across all its industry groups, barring Health & Public Service which saw a 1% dip versus the previous year. Financial Services recorded the highest growth at 15%. Products and Resources posted revenue increases of 9% and 8%, respectively. Revenues from Communications, Media & Technology increased 7% in Q4.

ADVERTISEMENT

Outlook

For the first quarter of 2026, Accenture expects revenues to range between $18.1-18.75 billion, representing growth of 1-5% year-over-year in local currency.

For fiscal year 2026, the company forecasts revenue growth of 2-5% in local currency. GAAP EPS is expected to be $13.19-13.57, representing a YoY growth of 9-12%. Adjusted EPS is projected to be $13.52-13.90, which represents a YoY increase of 5-8%.

ADVERTISEMENT